Levofloxacin-Proliposomes: Opportunities for Use in Lung Tuberculosis

Levofloxacin-Proliposomes: Opportunities for Use in Lung Tuberculosis

Levofloxacin (LEV) is a relatively new-generation fluoroquinolone antibiotic that has good activity against <em>Mycobacterium tuberculosis</em>. The aims of this study were to develop and evaluate LEV-proliposomes in a dry powder aerosol form for pulmonary delivery. LEV-p...

Full description

Bibliographic Details
Main Authors: Teerapol Srichana, Niracha Yanyium, Ekawat Thawithong, Titpawan Nakpheng, Wipaporn Rojanarat
Format: Article
Language:English
Published: MDPI AG 2012-08-01
Series:Pharmaceutics
Subjects:
dry powder inhaler
immunological response
levofloxacin
proliposome
tuberculosis
Online Access:http://www.mdpi.com/1999-4923/4/3/385

Internet

http://www.mdpi.com/1999-4923/4/3/385

Similar Items